Browsing Tag
CartiHeal
3 posts
Smith+Nephew Q3 2025: Can the CATALYSTEM rollout and REGENETEN momentum offset VBP risks?
Smith+Nephew raises 2025 free cash flow guidance to USD 750 million as margin growth accelerates. Find out what’s driving the company’s transformation.
Smith+Nephew wraps up $330m acquisition of CartiHeal to expand sports medicine reach
Smith+Nephew, a global leader in medical technology, has officially completed the acquisition of CartiHeal, the developer of Agili-C,…
Smith+Nephew announces $330m acquisition of CartiHeal for innovative cartilage regeneration technology
Smith+Nephew, a global medical technology leader, today announced its definitive agreement to acquire CartiHeal, the developer of Agili-C,…